Consensus Lazard NYSE

Stocks

LAZ

BMG540501027

Investment Management & Fund Operators

Market Closed - NYSE 21:00:02 31/08/2026 BST			5-day change	1st Jan Change
43.23 ^USD	-0.94%		-1.91%	+10.90%

08-27	Lazard Insider Sold Shares Worth $5,440,038, According to a Recent SEC Filing	MT
08-21	Record German debt sales deepen strains for Europe's battered bond market	RE

Evolution of the Average Target: Lazard

Evolution of the Target Price: Lazard

Changes in Analyst Recommendations: Lazard

c2d779dee2f4db3b0.MNUOUp0r3Dbylnpl1hRLl7sARmSxKtdTUxYX6JbS7Gs.AZp9PKVa7FO_1BszjHwv7fZJIy7cS5kFFmJV2_-b2VMd4T0m6hLuYpnHFQ~d15fcd101cf2408006e93a3ae36a4f44

Analysts' recommendations: Lazard

07-24	Morgan Stanley Adjusts Price Target on Lazard to $44 From $47, Maintains Underweight Rating	MT
07-10	BofA Adjusts Price Target on Lazard to $55 From $60	MT
07-09	Houlihan Lokey Estimates Cut by Morgan Stanley as Sponsor M&A Recovery Lags	MT
07-09	Morgan Stanley Adjusts Price Target on Lazard to $47 From $53, Maintains Underweight Rating	MT
05-04	UBS Adjusts Price Target on Lazard to $44 From $45, Maintains Neutral Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
05-04	Morgan Stanley Lifts Price Target on Lazard to $53 From $52, Keeps Underweight Rating	MT
04-14	Analyst recommendations: Biogen, Ford, Ge Vernova, Booking, Comcast…
04-10	BofA Securities Adjusts Price Target on Lazard to $63 From $65	MT
04-08	Wealth Brokers, Investment Banks Faced Uneven First-Quarter Activity, UBS Says	MT
04-08	UBS Adjusts Price Target on Lazard to $45 From $48, Maintains Neutral Rating	MT
04-08	Keefe, Bruyette & Woods Downgrades Lazard to Market Perform From Outperform, Adjusts Price Target to $47 From $62	MT
04-08	Analyst recommendations: Deere & Co, Verizon, Apollo Global Management, ServiceNow…
03-12	UBS Adjusts Lazard Price Target to $48 From $59, Maintains Neutral Rating	MT
01-30	UBS Adjusts Price Target on Lazard Inc to $59 From $54, Maintains Neutral Rating	MT
01-26	BofA Securities Initiates Coverage on Lazard With Buy Rating, $65 Price Target	MT
01-06	Morgan Stanley Trims Price Target on Lazard to $59 From $61, Keeps Underweight Rating	MT
24/10/25	Morgan Stanley Lifts Price Target on Lazard to $62 From $61, Keeps Underperform Rating	MT
03/10/25	BMO Capital Initiates Coverage on Lazard With Market Perform Rating, $56 Price Target	MT
18/09/25	Lazard, Inc. Appoints Geoffrey Porges as Managing Director in the Healthcare Advisory Group	CI
25/08/25	Analyst recommendations: Alaska Air, American Airlines, Dr Horton, Dollar Tree, Williams-Sonoma…
25/08/25	Keefe Bruyette & Woods Upgrades Lazard to Outperform From Market Perform, Adjusts PT to $65 From $60	MT
23/06/25	Analyst recommendations: Boston Properties, Dow, DraftKings, Estee Lauder, Jefferies…
09/04/25	UBS Adjusts Price Target on Lazard to $38 From $54, Maintains Neutral Rating	MT
03/02/25	UBS Adjusts Price Target on Lazard to $54 From $50, Maintains Neutral Rating	MT

More recommendations

Other Investment Management & Fund Operators

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BLACKROCK, INC.					+13.43%
	UBS GROUP AG					-0.95%
	BANK OF NEW YORK MELLON CORPORATION (THE)					+2.97%
	BROOKFIELD CORPORATION					+33.53%
	BROOKFIELD ASSET MANAGEMENT LTD.					+6.5%
	STATE STREET CORPORATION					+3.19%
	AMERIPRISE FINANCIAL, INC.					+3.6%
	3I GROUP PLC					+20.03%
	NORTHERN TRUST CORPORATION					-1.35%
	Average					+8.99%
	Weighted average by Cap.					+9.01%